![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, June 07, 2022 4:16:23 PM
OTCShotCaller
Bullish
07:58 AM
$RGBP
- Well folks it appears we've arrived! 100% PROOF Dr. Koos is on the right track with our Check-Point Inhibitor for treating Cancer!
Just out yesterday June 6, 2022, Oncologist Dr. Andrea Cercek at Memorial Sloan Kettering Cancer Center is interviewed on CNN regarding the results of a clinical trial on 14 patients with colorectal cancer treated with the Immunotherapy Drug Dostarlimab. All 14 patients had 100% disappearance of the rectal cancer within 24 weeks of treatment with little or no side effects.
youtube.com/watch?v=a0rbO3p...
Dostarlimab was developed by a Biotech by the name of Tesaro which was later bought by GlaxoSmithKline January 2019 for $5.1B. The results of the above study was published in The New England Journal of Medicine on June 5th that describes these historic results of all patents being cancer free after treatment.
beckersasc.com/gastroentero...
This is what I've mentioned here hundreds of times, i.e. we're entering into a Paradigm Shift in the Practice of Medicine.
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM